Tick-borne encephalitis vaccine (whole virus, inactivated)
- Generic Name
- Tick-borne encephalitis vaccine (whole virus, inactivated)
- Brand Names
- TicoVac
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 42XD79UQQ6
- Background
Tick-borne encephalitis (TBE) is a disease caused by the TBE virus (TBEV), transmitted by ticks from the genus Ixodes. The disease course is variable. Some patients will be asymptomatic or experience a mild febrile illness, while others will experience the full course including neurological symptoms. TBE often manifests in a biphasic manner, with patients ex...
- Indication
TICOVAC is indicated for active immunization against tick-borne encephalitis (TBE) in patients one year of age and older.
- Associated Conditions
- Meningoencephalitis viral, Tick Borne Encephalitis (TBE)
- Associated Therapies
- -
Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac
- First Posted Date
- 2012-10-19
- Last Posted Date
- 2018-08-03
- Lead Sponsor
- University of Surrey
- Target Recruit Count
- 40
- Registration Number
- NCT01710189
- Locations
- 🇬🇧
Surrey CRC, Egerton Road, Guildford, Surrey, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath